Disclosures for "Low-dose radiation followed by on-target inhibition of Galectin-3 in combination with anti-4-1BB monoclonal antibody regulates immune responses in Group 3 and Group 4 medulloblastoma mouse model ")
-
Dr. Cachia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for RedHill Biopharma Ltd. Dr. Cachia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GuidePoint Global LLC. Dr. Cachia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dedham Group. Dr. Cachia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Massachusetts Neurological Society.
-
Dr. Eskandari has nothing to disclose.
-
Mr. McDonald has nothing to disclose.
-
Dr. Infinger has nothing to disclose.
-
William A. Vandergrift has nothing to disclose.
-
Abhay K. Varma has nothing to disclose.
-
Sunil J. Patel has nothing to disclose.
-
Dr. Zukas has nothing to disclose.
-
Dr. Lindhorst has nothing to disclose.
-
Dr. DAS has nothing to disclose.